Levente Tocaciu
$INMD (Inmode Ltd) ๐Ÿ‘๐ซ๐ ๐ช๐ฎ๐š๐ซ๐ญ๐ž๐ซ ๐Ÿ๐ข๐ ๐ฎ๐ซ๐ž๐ฌ! Dear investors, I just went through the earning report for the Q3 of InMode released yesterday. ๐€๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ฒ: InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. It offers a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. ๐Š๐ž๐ฒ ๐Ÿ๐ข๐ ๐ฎ๐ซ๐ž๐ฌ: - revenue: 93,165mil USD - net income (profit): 21,863mil USD - gross margin: 78% - cash and cash equivalents of 532mil USD "๐บ๐‘Ÿ๐‘œ๐‘ ๐‘  ๐‘š๐‘Ž๐‘Ÿ๐‘”๐‘–๐‘›๐‘  ๐‘–๐‘› ๐‘กโ„Ž๐‘’ ๐‘กโ„Ž๐‘–๐‘Ÿ๐‘‘ ๐‘ž๐‘ข๐‘Ž๐‘Ÿ๐‘ก๐‘’๐‘Ÿ ๐‘ค๐‘’๐‘Ÿ๐‘’ ๐‘–๐‘› ๐‘™๐‘–๐‘›๐‘’ ๐‘ค๐‘–๐‘กโ„Ž ๐‘’๐‘ฅ๐‘๐‘’๐‘๐‘ก๐‘Ž๐‘ก๐‘–๐‘œ๐‘›๐‘  ๐‘Ž๐‘›๐‘‘ ๐‘Ÿ๐‘’๐‘“๐‘™๐‘’๐‘๐‘ก๐‘’๐‘‘ ๐‘œ๐‘ข๐‘Ÿ ๐‘๐‘Ÿ๐‘œ๐‘Ž๐‘๐‘ก๐‘–๐‘ฃ๐‘’ ๐‘๐‘™๐‘Ž๐‘›๐‘›๐‘–๐‘›๐‘” ๐‘Ž๐‘Ÿ๐‘œ๐‘ข๐‘›๐‘‘ ๐‘ก๐‘Ž๐‘Ÿ๐‘–๐‘“๐‘“ ๐‘–๐‘š๐‘๐‘Ž๐‘๐‘ก๐‘ ." - Yair Malca, CFO. ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค for full year 2025 - Revenues remain the same as in previous guidance between 365 million to 375 million - Non-GAAP gross margin remains the same as in previous guidance between 78% and 80% - Non-GAAP income from operations remains the same as in previous guidance to be between 93 million and 98 million I can only point out what I have already done. This small-cap company (with a market cap of less than 1 billion) generates a profit of about 100 million on 360 million in revenue - I think this is a strong sign of efficiency and competitive advantage. With 500 million in cash on hand and zero debt, investors are at ease. The situation in Israel is improving, but management is still aware of a possible escalation -> which could affect InMode's operations. The market is expecting a 5% revenue growth, which is a conservative approach due to the political situation. Any improvement will lead to higher projections, which will give the company a higher valuation, and so on. It looks cheap, nice, and perfect for investing. But we can't just ignore the risks. I already have an investment that is not recovering and is in a similar position, $FXPO.L (Ferrexpo PLC) - I will limit my risk by exposure. I am happy with the current size of the holding. A new valuation will come if the price changes. source: inmodeinvestors.com
null
.